NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球微載體市場

Microcarrier

出版商 Global Industry Analysts, Inc. 商品編碼 908131
出版日期 內容資訊 英文 373 Pages
商品交期: 最快1-2個工作天內
價格
全球微載體市場 Microcarrier
出版日期: 2021年04月01日內容資訊: 英文 373 Pages
簡介

本報告提供全球微載體市場相關調查,彙整市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業的簡介相關資訊。

第1章 調查方法

第2章 摘要整理

  • 市場概要
    • 競爭企業的市場佔有率
    • 全球市場佔有率方案
    • 各分類市場佔有率
    • 消耗品
    • 設備(產品)
  • 關注企業
  • 市場趨勢和促進因素
    • 隨著轉變到基於細胞生產的趨勢,對基於細胞的疫苗需求擴大正在加速增長
    • 作為感染疾病發病率上升對策的疫苗,其重要作用是市場需求的機會
    • 生技藥品的需求擴大與生物相似藥的機會
    • 由於持續性投資等原因對生物製劑的需求不斷增長 其他
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 非洲

第4章 競爭

  • CORNING
  • DANAHER CORPORATION
  • EPPENDORF AG
  • HIMEDIA LABORATORIES
  • LONZA GROUP AG
  • MERCK KGAA
  • SARTORIUS AG
  • THERMO FISHER SCIENTIFIC

第5章 相關調查

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP13304

Abstract:

Global Microcarrier Market to Reach $1.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Microcarrier estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$1.7 Billion by 2027, growing at aCAGR of 4.9% over the period 2020-2027. Equipment, one of the segments analyzed in the report, is projected to record 4.9% CAGR and reach US$424.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Consumables segment is readjusted to a revised 4.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $335.2 Million, While China is Forecast to Grow at 7.5% CAGR

The Microcarrier market in the U.S. is estimated at US$335.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$351.9 Million by the year 2027 trailing a CAGR of 7.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 4.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3% CAGR.

Select Competitors (Total 43 Featured) -

  • Becton, Dickinson and Company
  • Corning, Inc.
  • Danaher Corporation
  • Eppendorf AG
  • GE Healthcare
  • HiMedia Laboratories
  • Lonza Group AG
  • Merck KgaA
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • With Gradual Transition to Cell Based Production, Growing Demand for Cell Based Vaccines Fuels Market Growth
    • Vaccines Crucial Role in Tackling Rising Incidences of Infectious Diseases Presents Demand Opportunities in the Market: Global Vaccines Market (In US$ Billion) for the Years 2017, 2020 & 2022
    • Strong Demand for Biologics and Emerging Opportunities for Biosimilars Influence Market Prospects
    • Increasing Demand for Biologics Driven by Continuous Investments Extends Growth in the Market: Global Biologics Market (In US$ Billion) for the Years 2017, 2020 & 2023
    • Expanding Biosimilars Capabilities in Asia Pacific Triggers Demand in the Market
    • Rising Demand for Biosimilars in Asia Ramps up Market Prospects: Total Number of Biosimilars in Pipeline by Country (2018)
    • Pressing Need for Cost Effective Cell Production in Stem Cell and Gene Therapies Boosts Market Demand
    • With Cancer Related Conditions on the Rise in Asia, Ensuing Demand for Stem Cell and Gene Therapies Spurs Growth in the Global Market: Percentage (In %) Breakdown of New Cancer Cases by Geographic Region for the Year 2018
    • Ballooning VC Investments in the Biotech Space Drives Growth in the Market
    • Global Investment (In US$ Billion) in Biotech Space for the Years 2016, 2017 & 2018
    • Technological Advancements and New Product Launches Promise Cost Effective Cell Production
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Microcarrier by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Microcarrier by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Microcarrier by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Vaccine Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Vaccine Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Vaccine Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for CROs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 28: USA Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 29: USA Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: USA 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 31: USA Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: USA Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: USA 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 34: USA Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: USA Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: USA 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 37: Canada Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Canada Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: Canada 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 40: Canada Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Canada Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: Canada 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 43: Canada Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Canada Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: Canada 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 46: Japan Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Japan Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: Japan 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 49: Japan Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Japan Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: Japan 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 52: Japan Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Japan Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Japan 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 55: China Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: China Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: China 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 58: China Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: China Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: China 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 61: China Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: China Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: China 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 64: Europe Current & Future Analysis for Microcarrier by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 65: Europe Historic Review for Microcarrier by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: Europe 15-Year Perspective for Microcarrier by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 67: Europe Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Europe Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: Europe 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 70: Europe Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Europe Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Europe 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 73: Europe Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Europe Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Europe 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 76: France Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: France Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: France 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 79: France Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: France Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: France 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 82: France Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: France Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: France 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 85: Germany Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Germany Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: Germany 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 88: Germany Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Germany Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: Germany 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 91: Germany Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Germany Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Germany 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 94: Italy Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Italy Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Italy 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 97: Italy Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Italy Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Italy 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 100: Italy Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Italy Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: Italy 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 103: UK Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: UK Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: UK 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 106: UK Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: UK Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: UK 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 109: UK Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: UK Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: UK 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 112: Spain Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Spain Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: Spain 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 115: Spain Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Spain Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: Spain 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 118: Spain Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: Spain Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 120: Spain 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 121: Russia Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Russia Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 123: Russia 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 124: Russia Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: Russia Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 126: Russia 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 127: Russia Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Russia Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 129: Russia 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 130: Rest of Europe Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Rest of Europe Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 132: Rest of Europe 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 133: Rest of Europe Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Rest of Europe Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 135: Rest of Europe 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 136: Rest of Europe Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Rest of Europe Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 138: Rest of Europe 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 139: Asia-Pacific Current & Future Analysis for Microcarrier by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 140: Asia-Pacific Historic Review for Microcarrier by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 141: Asia-Pacific 15-Year Perspective for Microcarrier by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 142: Asia-Pacific Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Asia-Pacific Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 144: Asia-Pacific 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 145: Asia-Pacific Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Asia-Pacific Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 147: Asia-Pacific 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 148: Asia-Pacific Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Asia-Pacific Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 150: Asia-Pacific 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 151: Australia Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Australia Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 153: Australia 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 154: Australia Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Australia Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 156: Australia 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 157: Australia Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Australia Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 159: Australia 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 160: India Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 161: India Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 162: India 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 163: India Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 164: India Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 165: India 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 166: India Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 167: India Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 168: India 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 169: South Korea Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 170: South Korea Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 171: South Korea 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 172: South Korea Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 173: South Korea Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 174: South Korea 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 175: South Korea Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 176: South Korea Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 177: South Korea 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 178: Rest of Asia-Pacific Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 179: Rest of Asia-Pacific Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 180: Rest of Asia-Pacific 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 181: Rest of Asia-Pacific Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Rest of Asia-Pacific Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 183: Rest of Asia-Pacific 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 184: Rest of Asia-Pacific Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Rest of Asia-Pacific Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 186: Rest of Asia-Pacific 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 187: Latin America Current & Future Analysis for Microcarrier by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 188: Latin America Historic Review for Microcarrier by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 189: Latin America 15-Year Perspective for Microcarrier by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 190: Latin America Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 191: Latin America Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 192: Latin America 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 193: Latin America Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 194: Latin America Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 195: Latin America 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 196: Latin America Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 197: Latin America Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 198: Latin America 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 199: Argentina Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 200: Argentina Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 201: Argentina 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 202: Argentina Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 203: Argentina Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 204: Argentina 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 205: Argentina Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 206: Argentina Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 207: Argentina 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 208: Brazil Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 209: Brazil Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 210: Brazil 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 211: Brazil Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 212: Brazil Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 213: Brazil 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 214: Brazil Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 215: Brazil Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 216: Brazil 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 217: Mexico Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 218: Mexico Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 219: Mexico 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 220: Mexico Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 221: Mexico Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 222: Mexico 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 223: Mexico Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 224: Mexico Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 225: Mexico 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 226: Rest of Latin America Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 227: Rest of Latin America Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 228: Rest of Latin America 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 229: Rest of Latin America Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 230: Rest of Latin America Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 231: Rest of Latin America 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 232: Rest of Latin America Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 233: Rest of Latin America Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 234: Rest of Latin America 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 235: Middle East Current & Future Analysis for Microcarrier by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 236: Middle East Historic Review for Microcarrier by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 237: Middle East 15-Year Perspective for Microcarrier by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 238: Middle East Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 239: Middle East Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 240: Middle East 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 241: Middle East Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 242: Middle East Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 243: Middle East 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 244: Middle East Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 245: Middle East Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 246: Middle East 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 247: Iran Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 248: Iran Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 249: Iran 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 250: Iran Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 251: Iran Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 252: Iran 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 253: Iran Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 254: Iran Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 255: Iran 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 256: Israel Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 257: Israel Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 258: Israel 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 259: Israel Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 260: Israel Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 261: Israel 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 262: Israel Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 263: Israel Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 264: Israel 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 265: Saudi Arabia Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 266: Saudi Arabia Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 267: Saudi Arabia 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 268: Saudi Arabia Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 269: Saudi Arabia Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 270: Saudi Arabia 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 271: Saudi Arabia Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 272: Saudi Arabia Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 273: Saudi Arabia 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 274: UAE Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 275: UAE Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 276: UAE 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 277: UAE Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 278: UAE Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 279: UAE 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 280: UAE Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 281: UAE Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 282: UAE 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 283: Rest of Middle East Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 284: Rest of Middle East Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 285: Rest of Middle East 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 286: Rest of Middle East Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 287: Rest of Middle East Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 288: Rest of Middle East 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 289: Rest of Middle East Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 290: Rest of Middle East Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 291: Rest of Middle East 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 292: Africa Current & Future Analysis for Microcarrier by Product - Equipment and Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 293: Africa Historic Review for Microcarrier by Product - Equipment and Consumables Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 294: Africa 15-Year Perspective for Microcarrier by Product - Percentage Breakdown of Value Sales for Equipment and Consumables for the Years 2012, 2020 & 2027
    • TABLE 295: Africa Current & Future Analysis for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 296: Africa Historic Review for Microcarrier by Application - Vaccine Manufacturing, Cell Therapy and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 297: Africa 15-Year Perspective for Microcarrier by Application - Percentage Breakdown of Value Sales for Vaccine Manufacturing, Cell Therapy and Other Applications for the Years 2012, 2020 & 2027
    • TABLE 298: Africa Current & Future Analysis for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 299: Africa Historic Review for Microcarrier by End-Use - Pharmaceutical & Biotechnology Companies, Research Institutes and CROs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 300: Africa 15-Year Perspective for Microcarrier by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Research Institutes and CROs for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 43